SOPH — Sophia Genetics SA Share Price
0.000.00%
Last trade - 00:00- $299.42m
- $213.12m
- $62.37m
- 36
- 21
- 70
- 38
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.33 | ||
| Price to Tang. Book | 2.91 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.81 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -49.51% | ||
| Return on Equity | -46.03% | ||
| Operating Margin | -115.75% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 25.36 | 28.4 | 40.45 | 47.56 | 62.37 | 78.86 | 101.25 | 25.23% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- March 18th, 2011
- Public Since
- July 23rd, 2021
- No. of Shareholders
- 169
- No. of Employees
- 449
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 65,375,093
- Address
- La Piece 12, ROLLE, 1180
- Web
- https://www.sophiagenetics.com/
- Phone
- +41 216941060
- Auditors
- PricewaterhouseCoopers SA
Upcoming Events for SOPH
Q2 2024 Sophia Genetics SA Earnings Release
Q3 2024 Sophia Genetics SA Earnings Release
Similar to SOPH
2U
NASDAQ Global Select Market
ACV Auctions
NASDAQ Global Select Market
Adeia
NASDAQ Global Select Market
Adobe
NASDAQ Global Select Market
Agilysys
NASDAQ Global Select Market
FAQ
What is the Sophia Genetics SA share price?
As of Today at 23:23 UTC, shares in Sophia Genetics SA are trading at $4.72. This share price information is delayed by 15 minutes.
How has the Sophia Genetics SA share price performed this year?
Shares in Sophia Genetics SA last closed at $4.72 and the price had moved by +14.84% over the past 365 days. In terms of relative price strength the Sophia Genetics SA share price has underperformed the S&P500 Index by -8.62% over the past year.
What are the analyst and broker recommendations for Sophia Genetics SA?
The overall consensus recommendation for Sophia Genetics SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Sophia Genetics SA dividend yield?
Sophia Genetics SA does not currently pay a dividend.
Does Sophia Genetics SA pay a dividend?
Sophia Genetics SA does not currently pay a dividend.
When does Sophia Genetics SA next pay dividends?
Sophia Genetics SA does not currently pay a dividend.
How do I buy Sophia Genetics SA shares?
To buy shares in Sophia Genetics SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sophia Genetics SA?
As of the previous close price of $4.72, shares in Sophia Genetics SA had a market capitalisation of $308.57m.
Where are Sophia Genetics SA shares listed?
Here are the trading details for Sophia Genetics SA:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: SOPH
What kind of share is Sophia Genetics SA?
Based on an overall assessment of its quality, value and momentum Sophia Genetics SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sophia Genetics SA share price forecast for 2024?
The analyst consensus target price for shares in Sophia Genetics SA is $8.67. That is 83.69% above the last closing price of $4.72.
Analysts covering Sophia Genetics SA currently have a consensus Earnings Per Share (EPS) forecast of -$0.93 for the next financial year.
What is the trend in the Sophia Genetics SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sophia Genetics SA. Over the past six months, its share price has underperformed the S&P500 Index by -9.39%.
As of the last closing price of $4.72, shares in Sophia Genetics SA were trading +9.92% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sophia Genetics SA PE Ratio?
The Sophia Genetics SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $4.72.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sophia Genetics SA?
Sophia Genetics SA's management team is headed by:
- Jurgi Camblong - CEO
- Ross Muken - CFO
- Bram Goorden - COO
- Sergei Yakneen - SVP
- Philippe Menu - SVP